New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Response deadline
- May 7, 2027 Due in 220 days
- Date posted
- Nov 25, 2024
- Source
- Open notice
Description
The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease. Research can include healthy human participants of any age, specific clinical groups such as those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation to improve repeated measures across longer epochs of the lifespan, to better predict outcomes at later ages.
Classifications
- NAICS93.396
Documents (1)
- DownloadPAR-25-279-Full-Announcement.htmltext/html422 B
Contacts
- grantsinfo@nih.gov301-402-2541
Similar contracts
- Metastasis Research Network (U54 Clinical Trial Not Allowed)Due Sep 25, 2026
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)Due Nov 22, 2028
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)Due Jan 7, 2028
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)Due Jan 7, 2027
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)Due Jan 7, 2027
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Due Mar 5, 2029